Review Case Discussions 'New horizons improving gold standard therapy in acute stroke'

On June 22nd EVER Pharma conducted its 3rd webinar in 2022 titled ‘New horizons improving gold standard therapy in acute stroke - case discussions’.

The webinar was focusing on neurological emergencies – the treatment of ruptured SAH by intraventricular thrombolysis and acute ischemic stroke.

In the report you can find the summary of the 3 short presentations which focused on:

• What is IVF and how does it work, current evidence
• Cerebrolysin^® as add-on therapy after SAH coiling in severely affected patients
• Cerebrolysin^® as add-on therapy in AIS after recanalization therapy

In the end you find the take home messages of this webinar!

The full recording of the webinar you can find here.